<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03061786</url>
  </required_header>
  <id_info>
    <org_study_id>CCS-AKI P2011-2016</org_study_id>
    <nct_id>NCT03061786</nct_id>
  </id_info>
  <brief_title>Prognosis of Acute Kidney Injury:China Collaborative Study on AKI（CCS-AKI）Study</brief_title>
  <official_title>Prognosis of Acute Kidney Injury:China Collaborative Study on AKI（CCS-AKI）Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>XinLing Liang</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Guangdong Provincial People's Hospital</source>
  <brief_summary>
    <textblock>
      Acute kidney injury (AKI) is a common clinical syndrome, especially in the hospital patients.
      AKI is recognized as an important risk factor for incident chronic kidney disease,
      accelerated progression to end-stage renal disease,and increased risk of short-term and
      long-term mortality.This study is to observe the prognosis of hospitalized patients with AKI
      in China.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2017</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>estimated glomerular filtration rate decline</measure>
    <time_frame>2 years</time_frame>
    <description>&gt;50% baseline</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Chronic kidney disease classification upgrade</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>New cardiovascular events</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>All-cause mortality</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>AKI recovery</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rehospitalization</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">1000000</enrollment>
  <condition>Acute Kidney Injury</condition>
  <arm_group>
    <arm_group_label>AKI</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>non-AKI</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Hospitalized patients
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  clinically diagnosed with acute kidney injury, according to KDIGO criteria

        Exclusion Criteria:

          -  Nephrectomy

          -  Kidney transplantation

          -  Peak serum creatinine of less than 53µ mol/L

          -  Serum creatinine decrease after amputation

          -  Patients died during hospitalization

          -  End-stage kidney disease(chronic kidney disease stage 5)

          -  malnutrition
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Liang Xinling, MD,PhD</last_name>
    <phone>86-13808819770</phone>
    <email>xinlingliang@139.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Guangdong General Hospital</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Liang Xinling, MD,PhD</last_name>
      <phone>86-13808819770</phone>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>February 15, 2017</study_first_submitted>
  <study_first_submitted_qc>February 19, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">February 23, 2017</study_first_posted>
  <last_update_submitted>July 30, 2019</last_update_submitted>
  <last_update_submitted_qc>July 30, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 1, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Guangdong Provincial People's Hospital</investigator_affiliation>
    <investigator_full_name>XinLing Liang</investigator_full_name>
    <investigator_title>Director of Division of Nephrology and Blood Purification Center of Guangdong General Hospital</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acute Kidney Injury</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

